Russian medicine against coronavirus Avifavir (developed by KhimRar and RDIF) received a registration certificate from the Agency for Drug and Food Control of Indonesia (NADFC). This is stated in the press service of the Russian Direct Investment Fund (RDIF). Indonesia became the first Asian country to register the drug.
"The registration of the drug was conducted under an emergency use procedure based on data from an expanded phase II-III clinical trial, which was conducted in compliance with GCP rules from April to September 2020 in 30 specialized centers across Russia with the participation of 460 patients," the report says.
Pratapa Nirmala is a partner in the registration and sale of Avifavir in Indonesia.
About the drug
Avifavir is the first drug in Russia approved for use against coronavirus and the first registered drug in the world with the active ingredient favipiravir in the indication for the treatment of coronavirus. It is supplied to all regions of the Russian Federation and 15 countries of the world.
According to the results of studies, Avifavir demonstrated high efficacy in the complex treatment of patients hospitalized with new coronavirus infection. Thus, the average period of recovery in patients was four days instead of nine days with standard therapy, and the effectiveness of the drug was above 80%.
GSV "Russia - Islamic World"
Photo: Creative Commons
Based on materials from TASS